Difference between revisions of "Template:COVID-19 Testing, Reporting, and Information Management in the Laboratory/Final thoughts and additional resources/Key guidance documents"
From LIMSWiki
Jump to navigationJump to searchShawndouglas (talk | contribs) (Updated for August) |
Shawndouglas (talk | contribs) (November updates) |
||
Line 1: | Line 1: | ||
===5.2 Key guidance documents=== | ===5.2 Key guidance documents=== | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/ | * {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html |title=Guidance for SARS-CoV-2 Point-of-Care Testing |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=20 November 2020}} | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019- | * {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html |title=How to Report COVID-19 Laboratory Data |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=02 November 2020}} | ||
* {{cite web |url=https://www.cdc.gov/ | * {{cite web |url=https://www.cdc.gov/nchs/data/icd/10cmguidelines-FY2021.pdf |format=PDF |title=ICD-10-CM Official Guidelines for Coding and Reporting - FY 2021 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=01 October 2020}} | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html |title=Overview of Testing for SARS-CoV-2 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date= | * {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html |title=Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=05 November 2020}} | ||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html |title=Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=19 September 2020}} | |||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html |title=Overview of Testing for SARS-CoV-2 (COVID-19) |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=21 October 2020}} | |||
* {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/prelim-eval-criteria-digital-contact-tracing.pdf |title=Preliminary Criteria for the Evaluation of Digital Contact Tracing Tools for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 May 2020}} | * {{cite web |url=https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/prelim-eval-criteria-digital-contact-tracing.pdf |title=Preliminary Criteria for the Evaluation of Digital Contact Tracing Tools for COVID-19 |author=Centers for Disease Control and Prevention |publisher=Centers for Disease Control and Prevention |date=17 May 2020}} | ||
* {{cite web |url=https://ec.europa.eu/commission/presscorner/detail/en/QANDA_20_1905 |title=Coronavirus: EU interoperability gateway for contact tracing and warning apps – Questions and Answers |author=European Commission |publisher=European Union |date=19 October 2020}} | |||
* {{cite web |url=https://edpb.europa.eu/sites/edpb/files/files/file1/edpb_guidelines_20200420_contact_tracing_covid_with_annex_en.pdf |format=PDF |title=Guidelines 04/2020 on the use of location data and contact tracing tools in the context of the COVID-19 outbreak |author=European Data Protection Board |publisher=European Union |date=April 2020}} | * {{cite web |url=https://edpb.europa.eu/sites/edpb/files/files/file1/edpb_guidelines_20200420_contact_tracing_covid_with_annex_en.pdf |format=PDF |title=Guidelines 04/2020 on the use of location data and contact tracing tools in the context of the COVID-19 outbreak |author=European Data Protection Board |publisher=European Union |date=April 2020}} | ||
Line 19: | Line 25: | ||
* {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date=16 July 2020}} | * {{cite web |url=https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories |title=COVID-19: Guidance for sampling and for diagnostic laboratories |author=Public Health England |publisher=U.K Government |date=16 July 2020}} | ||
* {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date= | * {{cite web |url=https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19 |title=PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19) |author=Public Health Laboratory Network |publisher=Department of Health, Australian Government |date=12 November 2020}} | ||
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) |work=FDA-2020-D-1138 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=May 2020}} | * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health |title=Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised) |work=FDA-2020-D-1138 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=May 2020}} | ||
Line 26: | Line 32: | ||
* {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency |title=Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) |work=FDA-2020-D-0987-0049 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=15 May 2020}} | * {{cite web |url=https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency |title=Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised) |work=FDA-2020-D-0987-0049 |author=U.S. Food and Drug Administration |publisher=U.S. Food and Drug Administration |date=15 May 2020}} | ||
* {{cite web |url=https://apps.who.int/iris/handle/10665/335843 |title=Assessment tool for laboratories implementing SARS-CoV-2 testing: Interim guidance, 2 October 2020 |work=WHO/2019-nCoV/Lab_Assessment_Tool/2020.2 |author=World Health Organization, et al. |publisher=World Health Organization |date=02 October 2020}} | |||
* {{cite web |url=https://apps.who.int/iris/handle/10665/334254 |title=Diagnostic testing for SARS-CoV-2: Interim guidance, 11 September 2020 |work=WHO/2019-nCoV/laboratory/2020.6 |author=World Health Organization, et al. |publisher=World Health Organization |date=11 September 2020}} | |||
* {{cite web |url=https://apps.who.int/iris/handle/10665/332076 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020 |work=WHO/WPE/GIH/2020.3 |author=World Health Organization, et al. |publisher=World Health Organization |date=13 May 2020}} | * {{cite web |url=https://apps.who.int/iris/handle/10665/332076 |title=Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020 |work=WHO/WPE/GIH/2020.3 |author=World Health Organization, et al. |publisher=World Health Organization |date=13 May 2020}} | ||
Revision as of 18:45, 21 November 2020
5.2 Key guidance documents
- Centers for Disease Control and Prevention (20 November 2020). "Guidance for SARS-CoV-2 Point-of-Care Testing". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html.
- Centers for Disease Control and Prevention (2 November 2020). "How to Report COVID-19 Laboratory Data". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html.
- Centers for Disease Control and Prevention (1 October 2020). "ICD-10-CM Official Guidelines for Coding and Reporting - FY 2021" (PDF). Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/data/icd/10cmguidelines-FY2021.pdf.
- Centers for Disease Control and Prevention (5 November 2020). "Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html.
- Centers for Disease Control and Prevention (19 September 2020). "Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html.
- Centers for Disease Control and Prevention (21 October 2020). "Overview of Testing for SARS-CoV-2 (COVID-19)". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html.
- Centers for Disease Control and Prevention (17 May 2020). "Preliminary Criteria for the Evaluation of Digital Contact Tracing Tools for COVID-19". Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/prelim-eval-criteria-digital-contact-tracing.pdf.
- European Commission (19 October 2020). "Coronavirus: EU interoperability gateway for contact tracing and warning apps – Questions and Answers". European Union. https://ec.europa.eu/commission/presscorner/detail/en/QANDA_20_1905.
- European Data Protection Board (April 2020). "Guidelines 04/2020 on the use of location data and contact tracing tools in the context of the COVID-19 outbreak" (PDF). European Union. https://edpb.europa.eu/sites/edpb/files/files/file1/edpb_guidelines_20200420_contact_tracing_covid_with_annex_en.pdf.
- Occupational Safety and Health Administration (March 2020). "Guidance on Preparing Workplaces for COVID-19" (PDF). OSHA 3990-03 2020. Occupational Safety and Health Administration. https://www.osha.gov/Publications/OSHA3990.pdf.
- Pan American Health Organization (30 March 2020). "Laboratory Guidelines for the Detection and Diagnosis of COVID-19 Virus Infection" (PDF). Pan American Health Organization. https://www.paho.org/en/file/61863/download?token=4nO-2lxQ.
- Public Health England (16 July 2020). "COVID-19: Guidance for sampling and for diagnostic laboratories". U.K Government. https://www.gov.uk/government/publications/wuhan-novel-coronavirus-guidance-for-clinical-diagnostic-laboratories.
- Public Health Laboratory Network (12 November 2020). "PHLN guidance on laboratory testing for SARS-CoV-2 (the virus that causes COVID-19)". Department of Health, Australian Government. https://www.health.gov.au/resources/publications/phln-guidance-on-laboratory-testing-for-sars-cov-2-the-virus-that-causes-covid-19.
- U.S. Food and Drug Administration (May 2020). "Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised)". FDA-2020-D-1138. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-face-masks-and-respirators-during-coronavirus-disease-covid-19-public-health.
- U.S. Food and Drug Administration (30 March 2020). "Enforcement Policy for Gowns, Other Apparel, and Gloves During the Coronavirus Disease (COVID-19) Public Health Emergency". FDA-2020-D-1138-0023. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-gowns-other-apparel-and-gloves-during-coronavirus-disease-covid-19-public-health.
- U.S. Food and Drug Administration (15 May 2020). "Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)". FDA-2020-D-0987-0049. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-diagnostic-tests-coronavirus-disease-2019-during-public-health-emergency.
- World Health Organization, et al. (2 October 2020). "Assessment tool for laboratories implementing SARS-CoV-2 testing: Interim guidance, 2 October 2020". WHO/2019-nCoV/Lab_Assessment_Tool/2020.2. World Health Organization. https://apps.who.int/iris/handle/10665/335843.
- World Health Organization, et al. (11 September 2020). "Diagnostic testing for SARS-CoV-2: Interim guidance, 11 September 2020". WHO/2019-nCoV/laboratory/2020.6. World Health Organization. https://apps.who.int/iris/handle/10665/334254.
- World Health Organization, et al. (13 May 2020). "Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 13 May 2020". WHO/WPE/GIH/2020.3. World Health Organization. https://apps.who.int/iris/handle/10665/332076.